The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis

The novel formula of spiramycin/propolis loaded chitosan (CS)/alginate (Alg) nanoparticles (NPs) was assessed for Toxoplasma gondii (T. gondii) treatment in comparison with the commercially available spiramycin regarding tissue penetration and blood brain barrier (BBB) passage. Swiss Albino mice wer...

Full description

Bibliographic Details
Main Authors: Nancy Abd-elkader Hagras, Nermine Mogahed Fawzy Hussein Mogahed, Eman Sheta, Amira Abd-elfattah Darwish, Mohamed Ali El-hawary, Moaaz Tarek Hamed, Bassma Hassan Elwakil
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science (PLoS) 2022
Subjects:
Online Access:https://doaj.org/article/b5774997c43049abb0bd890315e5c70c
id ftdoajarticles:oai:doaj.org/article:b5774997c43049abb0bd890315e5c70c
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:b5774997c43049abb0bd890315e5c70c 2023-05-15T15:14:49+02:00 The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis Nancy Abd-elkader Hagras Nermine Mogahed Fawzy Hussein Mogahed Eman Sheta Amira Abd-elfattah Darwish Mohamed Ali El-hawary Moaaz Tarek Hamed Bassma Hassan Elwakil 2022-03-01T00:00:00Z https://doaj.org/article/b5774997c43049abb0bd890315e5c70c EN eng Public Library of Science (PLoS) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926208/?tool=EBI https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 https://doaj.org/article/b5774997c43049abb0bd890315e5c70c PLoS Neglected Tropical Diseases, Vol 16, Iss 3 (2022) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2022 ftdoajarticles 2022-12-31T03:35:33Z The novel formula of spiramycin/propolis loaded chitosan (CS)/alginate (Alg) nanoparticles (NPs) was assessed for Toxoplasma gondii (T. gondii) treatment in comparison with the commercially available spiramycin regarding tissue penetration and blood brain barrier (BBB) passage. Swiss Albino mice were inoculated intraperitoneally by 2500 tachyzoites of the virulent T. gondii RH strain. The experimental groups were treated with oral spiramycin, propolis, CS/Alg NPs, spiramycin loaded CS/Alg NPs, propolis loaded CS/Alg NPs, and spiramycin/propolis loaded CS/Alg NPs. The results demonstrated that spiramycin/propolis loaded CS/Alg NPs exerted the longest survival time with no mortality on the sacrifice day (8th) in addition to representing the highest significant parasite percent reduction of (≥96% reduction) in liver, spleen and brain designating successful tissue penetration and BBB passage. Tachyzoites treated with spiramycin/propolis loaded CS/Alg NPs demonstrated the most disfigured rapturing organism via scanning electron microscope examination along with representing an overall remarkable improvement of the histopathological pictures of liver, spleen and brain. In conclusion, spiramycin/propolis loaded CS/Alg NPs showed the uppermost efficacy in the treatment of acute murine toxoplasmosis. The safe nature and the anti-parasitic effect of each of CS, Alg, spiramycin and propolis encourage the synergistic use of spiramycin/propolis loaded CS/Alg NPs as a potent treatment for human toxoplasmosis. Author summary Toxoplasmosis is a disease that results from infection with a parasite known as Toxoplasma gondii (T. gondii). The parasite is considered to be one of the world’s most common parasites. Infection frequently occurs by eating undercooked contaminated meat, exposure to infected cat faeces, or mother-to-fetus transmission throughout pregnancy. The parasite has the ability to reach all body organs including the brain. This in turn, may lead to death specially among people with weakened immune systems and ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Nancy Abd-elkader Hagras
Nermine Mogahed Fawzy Hussein Mogahed
Eman Sheta
Amira Abd-elfattah Darwish
Mohamed Ali El-hawary
Moaaz Tarek Hamed
Bassma Hassan Elwakil
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
topic_facet Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
description The novel formula of spiramycin/propolis loaded chitosan (CS)/alginate (Alg) nanoparticles (NPs) was assessed for Toxoplasma gondii (T. gondii) treatment in comparison with the commercially available spiramycin regarding tissue penetration and blood brain barrier (BBB) passage. Swiss Albino mice were inoculated intraperitoneally by 2500 tachyzoites of the virulent T. gondii RH strain. The experimental groups were treated with oral spiramycin, propolis, CS/Alg NPs, spiramycin loaded CS/Alg NPs, propolis loaded CS/Alg NPs, and spiramycin/propolis loaded CS/Alg NPs. The results demonstrated that spiramycin/propolis loaded CS/Alg NPs exerted the longest survival time with no mortality on the sacrifice day (8th) in addition to representing the highest significant parasite percent reduction of (≥96% reduction) in liver, spleen and brain designating successful tissue penetration and BBB passage. Tachyzoites treated with spiramycin/propolis loaded CS/Alg NPs demonstrated the most disfigured rapturing organism via scanning electron microscope examination along with representing an overall remarkable improvement of the histopathological pictures of liver, spleen and brain. In conclusion, spiramycin/propolis loaded CS/Alg NPs showed the uppermost efficacy in the treatment of acute murine toxoplasmosis. The safe nature and the anti-parasitic effect of each of CS, Alg, spiramycin and propolis encourage the synergistic use of spiramycin/propolis loaded CS/Alg NPs as a potent treatment for human toxoplasmosis. Author summary Toxoplasmosis is a disease that results from infection with a parasite known as Toxoplasma gondii (T. gondii). The parasite is considered to be one of the world’s most common parasites. Infection frequently occurs by eating undercooked contaminated meat, exposure to infected cat faeces, or mother-to-fetus transmission throughout pregnancy. The parasite has the ability to reach all body organs including the brain. This in turn, may lead to death specially among people with weakened immune systems and ...
format Article in Journal/Newspaper
author Nancy Abd-elkader Hagras
Nermine Mogahed Fawzy Hussein Mogahed
Eman Sheta
Amira Abd-elfattah Darwish
Mohamed Ali El-hawary
Moaaz Tarek Hamed
Bassma Hassan Elwakil
author_facet Nancy Abd-elkader Hagras
Nermine Mogahed Fawzy Hussein Mogahed
Eman Sheta
Amira Abd-elfattah Darwish
Mohamed Ali El-hawary
Moaaz Tarek Hamed
Bassma Hassan Elwakil
author_sort Nancy Abd-elkader Hagras
title The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
title_short The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
title_full The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
title_fullStr The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
title_full_unstemmed The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
title_sort powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
publisher Public Library of Science (PLoS)
publishDate 2022
url https://doaj.org/article/b5774997c43049abb0bd890315e5c70c
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source PLoS Neglected Tropical Diseases, Vol 16, Iss 3 (2022)
op_relation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926208/?tool=EBI
https://doaj.org/toc/1935-2727
https://doaj.org/toc/1935-2735
1935-2727
1935-2735
https://doaj.org/article/b5774997c43049abb0bd890315e5c70c
_version_ 1766345222674972672